Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-low Split-dose Oral Lactulose vs High-volume Split-dose Polyethylene Glycol as Bowel Preparation for Outpatient Colonoscopies (LACPEG): Randomized, Single-center, Single-blind Clinical Trial.

NCT07787897 is registered in ClinicalTrials.gov with National Institute of Medical Sciences and Nutrition, Salvador Zubiran as lead sponsor.

NCT NCT07787897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07787897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-low Split-dose Oral Lactulose vs High-volume Split-dose Polyethylene Glycol as Bowel Preparation for Outpatient Colonoscopies (LACPEG): Randomized, Single-center, Single-blind Clinical Trial.
Lead sponsor
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2024
Completion date
December 31, 2025
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonoscopy